Anil Diwan

All filings by Anil Diwan on record concern Nanoviricides, Inc. The record holds 109 filings, for trades running from 15 February 2011 to 8 August 2022.

On the open market, the record shows 19 purchases worth €478k and 84 sales worth €2.5M. On balance, insiders were net sellers of €2.0M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant and 1 option exercise.

In size, the median ticket on the buying side is €13k. For 16 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -12.8%. These figures describe past trades and do not predict future prices.

On 10 August 2022 came the latest disclosure, a transaction in Nanoviricides, Inc. The most recent open-market purchase was published on 13 January 2015, 4,317 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.